326030 — SK Biopharmaceuticals Share News
0.000.00%
Last trade - 00:00- KR₩6tn
- KR₩5tn
- KR₩707bn
WHO chief says drug firms should share vaccine-making capacity (updated)
Indebted South Korea retail stock buyers face reality check as short selling to resume
South Korea's IPO market poised for record year on booming retail demand
South Korea's IPO market poised for record year on booming retail demand
Italy's healthcare group Angelini buys Swiss-based Arvelle in $1 bln deal
Vaccine developer SK Bioscience targets IPO in first half of 2021 (updated)
Signed An Agreement With Lifesci Venture Partners To Collaborate On Open Innovation Through A Fund
Brief: SK Biopharmaceuticals says Co And Ono Pharmaceutical Enter Licensing Agreement For Cenobamate In Japan
Brief: Sk Biopharmaceuticals Signs Technology Transfer Agreement Worth $505 Mln With Ono Pharmaceutical Co
Fans of boy band BTS join swarm of Ants chasing S.Korea's hit IPO
S.Korean shares surge on upbeat U.S. data, virus vaccine hopes
S.Korean shares track Wall St higher; SK Biopharmaceuticals jumps on debut
S.Korea's SK Biopharmaceuticals shares soar 30% in market debut (updated)
S.Korea's SK Biopharmaceuticals shares debut at double IPO price